about
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's...
Read More
33.80
1.38
(4.26%)
1.0M
XNAS Volume
XNAS 22 Sep, 2026 4:19 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Kodiak Sciences Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..